Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer

Chen et al. (Mon,) studied this question.

www.synapsesocial.com/papers/69d97eef0d540cafc5835ddb — DOI: https://doi.org/10.1186/s13045-021-01089-z

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?· 2019 · 1,705 citations
2. The National Comprehensive Cancer Network· 1998 · 16,869 citations
3. Liquid biopsy: monitoring cancer-genetics in the blood· 2013 · 1,842 citations
4. Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version)· 2019 · 246 citations
5. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies· 2014 · 5,064 citations